151 related articles for article (PubMed ID: 38044878)
1. A review of prophylactic regimens to prevent invasive fungal infections in hematology patients undergoing chemotherapy or stem cell transplantation.
Criscuolo M; Fracchiolla N; Farina F; Verga L; Pagano L; Busca A
Expert Rev Hematol; 2023; 16(12):963-980. PubMed ID: 38044878
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a primary antifungal prophylaxis protocol for preventing invasive mold infections after allogeneic hematopoietic stem cell transplantation.
Herity LB; Cruz OA; Aziz MT
J Oncol Pharm Pract; 2022 Jun; 28(4):794-804. PubMed ID: 33906508
[TBL] [Abstract][Full Text] [Related]
3. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience.
Busca A; Cinatti N; Gill J; Passera R; Dellacasa CM; Giaccone L; Dogliotti I; Manetta S; Corcione S; De Rosa FG
Front Cell Infect Microbiol; 2021; 11():805514. PubMed ID: 35071052
[TBL] [Abstract][Full Text] [Related]
4. Approach to diagnostic evaluation and prevention of invasive fungal disease in patients prior to allogeneic hematopoietic stem cell transplant.
O'Keeffe JC; Singh N; Slavin MA
Transpl Infect Dis; 2023 Nov; 25 Suppl 1():e14197. PubMed ID: 37988269
[TBL] [Abstract][Full Text] [Related]
5. [Invasive fungal infection management in patients with hematological malignancies].
Kanda Y
Rinsho Ketsueki; 2022; 63(9):1270-1278. PubMed ID: 36198553
[TBL] [Abstract][Full Text] [Related]
6. Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease.
Luu Tran H; Mahmoudjafari Z; Rockey M; Henry D; Grauer D; Aljitawi O; Abhyankar S; Ganguly S; Lin T; McGuirk J
J Oncol Pharm Pract; 2016 Apr; 22(2):228-34. PubMed ID: 25471252
[TBL] [Abstract][Full Text] [Related]
7. A Single-Center, Open-Label Trial of Isavuconazole Prophylaxis against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
Stern A; Su Y; Lee YJ; Seo S; Shaffer B; Tamari R; Gyurkocza B; Barker J; Bogler Y; Giralt S; Perales MA; Papanicolaou GA
Biol Blood Marrow Transplant; 2020 Jun; 26(6):1195-1202. PubMed ID: 32088367
[TBL] [Abstract][Full Text] [Related]
8. Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection.
Pepeler MS; Yildiz Ş; Yegin ZA; Özkurt ZN; Tunçcan ÖG; Erbaş G; Köktürk N; Kalkanci A; Yildirim Z
J Infect Dev Ctries; 2018 Sep; 12(9):799-805. PubMed ID: 31999640
[TBL] [Abstract][Full Text] [Related]
9. Voriconazole for prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplantation.
Marks DI; Liu Q; Slavin M
Expert Rev Anti Infect Ther; 2017 May; 15(5):493-502. PubMed ID: 28335642
[TBL] [Abstract][Full Text] [Related]
10. Long-Lasting Protective Effect of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
Busca A; Candoni A; Audisio E; Passera R; Bruno B; Monaco F; Mordini N; Vacca A; Delia M; Aversa F; Pagano L
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2214-2219. PubMed ID: 27667012
[TBL] [Abstract][Full Text] [Related]
11. Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis.
Ziakas PD; Kourbeti IS; Mylonakis E
Clin Ther; 2014 Feb; 36(2):292-306.e1. PubMed ID: 24439393
[TBL] [Abstract][Full Text] [Related]
12. Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
Mellinghoff SC; Panse J; Alakel N; Behre G; Buchheidt D; Christopeit M; Hasenkamp J; Kiehl M; Koldehoff M; Krause SW; Lehners N; von Lilienfeld-Toal M; Löhnert AY; Maschmeyer G; Teschner D; Ullmann AJ; Penack O; Ruhnke M; Mayer K; Ostermann H; Wolf HH; Cornely OA
Ann Hematol; 2018 Feb; 97(2):197-207. PubMed ID: 29218389
[TBL] [Abstract][Full Text] [Related]
13. The clinical management of invasive mold infection in children with cancer or undergoing hematopoietic stem cell transplantation.
Lehrnbecher T
Expert Rev Anti Infect Ther; 2019 Jul; 17(7):489-499. PubMed ID: 31149864
[No Abstract] [Full Text] [Related]
14. [Prophylactic strategies for invasive fungal infections after allogeneic hematopoietic stem cell transplantation].
Asano-Mori Y
Rinsho Ketsueki; 2016; 57(10):2208-2217. PubMed ID: 27795532
[TBL] [Abstract][Full Text] [Related]
15. Real-world assessment of the effectiveness of posaconazole for the prophylaxis and treatment of invasive fungal infections in hematological patients: A retrospective observational study.
Chen X; Wang J; Wang S; Jin J; Li J; Gao S; Li J; Li J; Liu Q; Hu Y; Lin D; Sun Z; Yang J; Hu J; Wu X; Huang X; Shao Z; Deng Q; Wang C; Liu L; Chen H; Wang J; Wei X; Shen J; Zhang X; Wu D
Medicine (Baltimore); 2021 Jul; 100(30):e26772. PubMed ID: 34397725
[TBL] [Abstract][Full Text] [Related]
16. Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantation.
Rosillo C; Avila AM; Huang YT; Devlin S; Cho C; Montoro J; Maloy MA; Papanicolaou GA; Barba P; Perales MA
Transpl Infect Dis; 2018 Aug; 20(4):e12897. PubMed ID: 29668073
[TBL] [Abstract][Full Text] [Related]
17. Fungal Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patients.
Bays DJ; Thompson GR
Infect Dis Clin North Am; 2019 Jun; 33(2):545-566. PubMed ID: 31005138
[TBL] [Abstract][Full Text] [Related]
18. Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions.
Lionakis MS; Lewis RE; Kontoyiannis DP
Clin Infect Dis; 2018 Oct; 67(10):1621-1630. PubMed ID: 29860307
[TBL] [Abstract][Full Text] [Related]
19. High rate of invasive fungal infections after non-T cell depleted haploidentical allo-HSCT even under antifungal prophylaxis.
Lien MY; Yeh SP; Gau JP; Wang PN; Li SS; Dai MS; Chen TC; Hsieh PY; Chiou LW; Huang WH; Liu YC; ; Ko BS
Bone Marrow Transplant; 2021 Jul; 56(7):1750-1753. PubMed ID: 33782547
[No Abstract] [Full Text] [Related]
20. Clinical and pharmacoeconomic evaluation of antifungal prophylaxis with continuous micafungin in patients undergoing allogeneic stem cell transplantation: A six-year cohort analysis.
Wingen-Heimann SM; Cornely OA; Vehreschild MJGT; Wisplinghoff H; Franke B; Schons M; von Bergwelt-Baildon M; Scheid C; Vehreschild JJ
Mycoses; 2021 Apr; 64(4):437-444. PubMed ID: 33354800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]